A detailed history of Lsv Asset Management transactions in Amgen Inc stock. As of the latest transaction made, Lsv Asset Management holds 614,860 shares of AMGN stock, worth $162 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
614,860
Previous 766,190 19.75%
Holding current value
$162 Million
Previous $239 Million 17.24%
% of portfolio
0.42%
Previous 0.52%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $46.8 Million - $51.1 Million
-151,330 Reduced 19.75%
614,860 $198 Million
Q2 2024

Aug 06, 2024

SELL
$262.75 - $319.31 $156 Million - $190 Million
-593,924 Reduced 43.67%
766,190 $239 Million
Q1 2024

May 06, 2024

SELL
$268.87 - $324.56 $126 Million - $153 Million
-470,087 Reduced 25.68%
1,360,114 $387 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $26.3 Million - $29.6 Million
-102,747 Reduced 5.32%
1,830,201 $527 Million
Q3 2023

Nov 03, 2023

SELL
$218.65 - $271.46 $21.4 Million - $26.6 Million
-98,070 Reduced 4.83%
1,932,948 $519 Million
Q2 2023

Aug 02, 2023

SELL
$214.27 - $253.37 $18.1 Million - $21.4 Million
-84,300 Reduced 3.99%
2,031,018 $451 Million
Q1 2023

May 02, 2023

SELL
$225.79 - $275.2 $18.4 Million - $22.4 Million
-81,438 Reduced 3.71%
2,115,318 $511 Million
Q4 2022

Feb 08, 2023

SELL
$229.03 - $291.01 $27.9 Million - $35.5 Million
-121,830 Reduced 5.25%
2,196,756 $577 Million
Q3 2022

Nov 07, 2022

SELL
$224.46 - $253.15 $4.7 Million - $5.3 Million
-20,930 Reduced 0.89%
2,318,586 $523 Million
Q2 2022

Aug 10, 2022

SELL
$230.71 - $256.74 $13.7 Million - $15.2 Million
-59,376 Reduced 2.48%
2,339,516 $569 Million
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $12.6 Million - $14 Million
57,674 Added 2.46%
2,398,892 $580 Million
Q4 2021

Jan 28, 2022

SELL
$198.88 - $227.6 $6.01 Million - $6.87 Million
-30,200 Reduced 1.27%
2,341,218 $527 Million
Q3 2021

Nov 04, 2021

SELL
$212.27 - $248.7 $4.29 Million - $5.03 Million
-20,225 Reduced 0.85%
2,371,418 $504 Million
Q2 2021

Aug 04, 2021

SELL
$233.58 - $259.14 $5.16 Million - $5.73 Million
-22,110 Reduced 0.92%
2,391,643 $583 Million
Q1 2021

Apr 30, 2021

SELL
$221.91 - $258.6 $31.1 Million - $36.3 Million
-140,258 Reduced 5.49%
2,413,753 $601 Million
Q4 2020

Feb 08, 2021

SELL
$216.38 - $257.67 $38.4 Million - $45.7 Million
-177,529 Reduced 6.5%
2,554,011 $587 Million
Q3 2020

Oct 23, 2020

SELL
$234.65 - $260.95 $29.5 Million - $32.8 Million
-125,599 Reduced 4.4%
2,731,540 $694 Million
Q2 2020

Aug 05, 2020

SELL
$197.81 - $242.74 $93.1 Million - $114 Million
-470,657 Reduced 14.14%
2,857,139 $674 Million
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $31 Million - $41.1 Million
-170,131 Reduced 4.86%
3,327,796 $675 Million
Q4 2019

Feb 10, 2020

SELL
$189.21 - $243.2 $31.9 Million - $40.9 Million
-168,357 Reduced 4.59%
3,497,927 $843 Million
Q3 2019

Nov 07, 2019

SELL
$174.11 - $208.62 $25.4 Million - $30.4 Million
-145,890 Reduced 3.83%
3,666,284 $709 Million
Q2 2019

Aug 08, 2019

SELL
$166.7 - $195.41 $16.2 Million - $19 Million
-97,231 Reduced 2.49%
3,812,174 $703 Million
Q1 2019

May 07, 2019

SELL
$180.87 - $203.88 $20.8 Million - $23.5 Million
-115,224 Reduced 2.86%
3,909,405 $743 Million
Q4 2018

Feb 05, 2019

SELL
$178.4 - $208.25 $12 Million - $14.1 Million
-67,474 Reduced 1.65%
4,024,629 $783 Million
Q3 2018

Nov 06, 2018

SELL
$185.29 - $208.89 $12.1 Million - $13.7 Million
-65,546 Reduced 1.58%
4,092,103 $848 Million
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $21.4 Million - $24 Million
128,865 Added 3.2%
4,157,649 $767 Million
Q1 2018

May 04, 2018

BUY
$169.43 - $198.0 $36.3 Million - $42.4 Million
214,013 Added 5.61%
4,028,784 $687 Million
Q4 2017

Feb 01, 2018

BUY
$168.79 - $188.59 $39.6 Million - $44.2 Million
234,461 Added 6.55%
3,814,771 $0
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $599 Million - $684 Million
3,580,310
3,580,310 $668 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.